These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection. Tong Y; Zhu Y; Xia X; Liu Y; Feng Y; Hua X; Chen Z; Ding H; Gao L; Wang Y; Feitelson MA; Zhao P; Qi ZT J Virol; 2011 Mar; 85(6):2793-802. PubMed ID: 21177818 [TBL] [Abstract][Full Text] [Related]
9. Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps. Dao Thi VL; Granier C; Zeisel MB; Guérin M; Mancip J; Granio O; Penin F; Lavillette D; Bartenschlager R; Baumert TF; Cosset FL; Dreux M J Biol Chem; 2012 Sep; 287(37):31242-57. PubMed ID: 22767607 [TBL] [Abstract][Full Text] [Related]
10. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. Bitzegeio J; Bankwitz D; Hueging K; Haid S; Brohm C; Zeisel MB; Herrmann E; Iken M; Ott M; Baumert TF; Pietschmann T PLoS Pathog; 2010 Jul; 6(7):e1000978. PubMed ID: 20617177 [TBL] [Abstract][Full Text] [Related]
11. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. Dreux M; Dao Thi VL; Fresquet J; Guérin M; Julia Z; Verney G; Durantel D; Zoulim F; Lavillette D; Cosset FL; Bartosch B PLoS Pathog; 2009 Feb; 5(2):e1000310. PubMed ID: 19229312 [TBL] [Abstract][Full Text] [Related]
12. Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission. Catanese MT; Loureiro J; Jones CT; Dorner M; von Hahn T; Rice CM J Virol; 2013 Aug; 87(15):8282-93. PubMed ID: 23698298 [TBL] [Abstract][Full Text] [Related]
13. A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I. Zuiani A; Chen K; Schwarz MC; White JP; Luca VC; Fremont DH; Wang D; Evans MJ; Diamond MS J Virol; 2016 Dec; 90(23):10499-10512. PubMed ID: 27630236 [TBL] [Abstract][Full Text] [Related]
14. Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry. Prentoe J; Bukh J Front Immunol; 2018; 9():2146. PubMed ID: 30319614 [TBL] [Abstract][Full Text] [Related]
15. Effect of cell polarization on hepatitis C virus entry. Mee CJ; Grove J; Harris HJ; Hu K; Balfe P; McKeating JA J Virol; 2008 Jan; 82(1):461-70. PubMed ID: 17959672 [TBL] [Abstract][Full Text] [Related]
16. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma. Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454 [TBL] [Abstract][Full Text] [Related]
17. Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants. Catanese MT; Ansuini H; Graziani R; Huby T; Moreau M; Ball JK; Paonessa G; Rice CM; Cortese R; Vitelli A; Nicosia A J Virol; 2010 Jan; 84(1):34-43. PubMed ID: 19828610 [TBL] [Abstract][Full Text] [Related]
18. Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission. Fan H; Qiao L; Kang KD; Fan J; Wei W; Luo G J Virol; 2017 Jul; 91(13):. PubMed ID: 28404852 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection of neuroepithelioma cell lines. Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002 [TBL] [Abstract][Full Text] [Related]
20. New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A. Fénéant L; Potel J; François C; Sané F; Douam F; Belouzard S; Calland N; Vausselin T; Rouillé Y; Descamps V; Baumert TF; Duverlie G; Lavillette D; Hober D; Dubuisson J; Wychowski C; Cocquerel L J Virol; 2015 Aug; 89(16):8346-64. PubMed ID: 26041282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]